ABOUT DIAMYD MEDICAL
ABOUT DIAMYD MEDICAL
CEO Comments
The Diamyd Story
Board & Management
Contact Us
Corporate Governance
Annual General Meeting
Extraordinary General Meetings
Nomination Committee
Board & Management
Auditors
Corporate Governance Report
Articles of Incorporation
Remuneration Principles
Incentive Programs
Diamyd US Operations
Partnering
DIABETES
DIABETES
Type 1
LADA
Type 2
Complications
Diamyd
®
Products
PRODUCTS & PIPELINE
PRODUCTS & PIPELINE
Diamyd
®
Products
Diamyd
®
for type 1
Diamyd
®
for LADA
NTDDS products
NP2
NG2
NC3
Partnering
SCIENCE & TECHNOLOGY
SCIENCE & TECHNOLOGY
GAD platform
NTDDS platform
Clinical development
Scientific publications
Scientific advisory board
CLINICAL TRIALS
CLINICAL TRIALS
Phase III Trials - USA
Phase III Trials - Europe
INVESTOR RELATIONS
INVESTOR RELATIONS
Press Releases
Financial Reports
IR Calendar
Owners
Share Trading
Board & Management
Corporate Governance
Annual General Meeting
Extraordinary General Meetings
Nomination Committee
Board & Management
Auditors
Corporate Governance Report
Articles of Incorporation
Remuneration Principles
Incentive Programs
PRESS ROOM
PRESS ROOM
Press Releases
News & Mediawatch
Webcasts/Podcasts
Newsletter Subscription
Media Contact
Home
»
Investor Relations
»
Financial Reports
Financial reports
Svenska
English
2010
2009
2008
Older
7/1/2010
Quarterly Report III 09/10
4/28/2010
Quarterly Report II 09/10
1/29/2010
Quarterly Report I 09/10
Investor Relations
Press Releases
Financial Reports
IR Calendar
Owners
Share Trading
Board & Management
Corporate Governance
Annual General Meeting
Extraordinary General Meetings
Nomination Committee
Board & Management
Auditors
Corporate Governance Report
Articles of Incorporation
Remuneration Principles
Incentive Programs
The Diamyd share
Related links
Newsletter subscription